Interleukin Genetics Inc (ILIU)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Interleukin Genetics Inc (ILIU) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010920
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Interleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include ILUSTRA genetic risk test ; cardiovascular risk test; weight management genetic test; bone health genetic test; heart health genetic test; nutritional needs genetic test; and wellness select genetic test. ILUSTRA genetic test analyzes genetic variations associated with inflammation and helps in identifying individuals who are at increased risk for severe periodontal disease. The company distributes its products through partnership with healthcare professionals, health and wellness companies, and distribution channels. Interleukin is headquartered in Waltham, Massachusetts, the US.

Interleukin Genetics Inc (ILIU) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Interleukin Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Interleukin Genetics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Interleukin Genetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Interleukin Genetics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Interleukin Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Interleukin Genetics Inc, Medical Equipment, Deal Details 10
Partnerships 10
Interleukin Genetics Enters into Licensing Agreement with NYU School of Medicine 10
Interleukin Genetics Enters Into Research Collaboration With Metagenics 11
Access Business Group Enters into Licensing Agreement with Interleukin Genetics 12
Equity Offering 13
Interleukin Genetics Raises USD5.6 Million in Private Placement of Shares 13
Interleukin Genetics Raises USD5 Million in Private Placement of Shares and Warrants 15
Interleukin Genetics Completes Private Placement Of Shares And Warrants For US$12 Million 16
Interleukin Genetics Completes Private Placement Of Series B Convertible Preferred Stock For US$3 Million 17
Debt Offering 18
Interleukin Genetics Raises USD1 million in Issue of Subordinated Convertible Promissory Notes 18
Asset Transactions 19
Orig3N Acquires CLIA laboratory and Remaining Assets from Interleukin Genetics 19
Interleukin Genetics Inc – Key Competitors 20
Interleukin Genetics Inc – Key Employees 21
Interleukin Genetics Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
May 12, 2017: Interleukin Genetics Reports First Quarter 2017 Financial Results 23
Apr 18, 2017: Interleukin Genetics Reports Fourth Quarter and Year-End 2016 Financial Results 25
Nov 15, 2016: Interleukin Genetics Reports Third Quarter 2016 Financial Results 27
Aug 16, 2016: Interleukin Genetics Reports Second Quarter 2016 Financial Results 29
May 16, 2016: Interleukin Genetics Reports First Quarter 2016 Financial Results 31
Mar 17, 2016: Interleukin Genetics Reports Fourth Quarter and Year-End 2015 Financial Results 33
Corporate Communications 35
Jul 03, 2017: Interleukin Genetics To Explore Strategic Alternatives, Reduce Workforce 35
Aug 03, 2016: Interleukin Genetics Strengthens Commercial Leadership with Key Appointments 36
Mar 16, 2016: Interleukin Genetics Appoints Global Clinical Advisory Board To Guide Enhanced Healthcare through Targeted Management of Systemic Inflammation 37
Product News 38
Nov 03, 2016: Interleukin Genetics Launches The ILUSTRA Inflammation Management Program 38
Other Significant Developments 39
Feb 23, 2017: Interleukin Genetics Deploys ILUSTRA Inflammation Management Program with mPulse Mobile Employees 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Interleukin Genetics Inc, Medical Equipment, Key Facts, 2016 2
Interleukin Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Interleukin Genetics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Interleukin Genetics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Interleukin Genetics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Interleukin Genetics Inc, Deals By Market, 2011 to YTD 2017 8
Interleukin Genetics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Interleukin Genetics Enters into Licensing Agreement with NYU School of Medicine 10
Interleukin Genetics Enters Into Research Collaboration With Metagenics 11
Access Business Group Enters into Licensing Agreement with Interleukin Genetics 12
Interleukin Genetics Raises USD5.6 Million in Private Placement of Shares 13
Interleukin Genetics Raises USD5 Million in Private Placement of Shares and Warrants 15
Interleukin Genetics Completes Private Placement Of Shares And Warrants For US$12 Million 16
Interleukin Genetics Completes Private Placement Of Series B Convertible Preferred Stock For US$3 Million 17
Interleukin Genetics Raises USD1 million in Issue of Subordinated Convertible Promissory Notes 18
Orig3N Acquires CLIA laboratory and Remaining Assets from Interleukin Genetics 19
Interleukin Genetics Inc, Key Competitors 20
Interleukin Genetics Inc, Key Employees 21

★海外企業調査レポート[Interleukin Genetics Inc (ILIU)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Campine NV (CAMB):企業の財務・戦略的SWOT分析
    Campine NV (CAMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • AccuVein Inc:医療機器:M&Aディール及び事業提携情報
    Summary AccuVein Inc (AccuVein) is a medical device company that provides medical imaging solutions. The company’s products include AV400 vein viewing system, HF470 extended reach powered wheeled stand, HF450 unpowered wheeled stand, and HF410 hands-free solution. Its AV400 vein viewing system digit …
  • McDermott International Inc (MDR):石油・ガス:M&Aディール及び事業提携情報
    Summary McDermott International Inc (MII) is a provider of integrated engineering, procurement, construction and installation (EPCI), front-end engineering and design (FEED) and module fabrication services for upstream field developments. It delivers fixed and floating production facilities, pipelin …
  • TIE Kinetix NV (TIE):企業の財務・戦略的SWOT分析
    TIE Kinetix NV (TIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • QuadraMed Corp-医療機器分野:企業M&A・提携分析
    Summary Quadramed Corporation (Quadramed) is a healthcare technologies and service provider. It provides solutions to various healthcare organizations to improve the safety, efficiency and quality of patient care. The company's solutions enable its clients in streamlining processes, increase product …
  • BOE Technology Group Co Ltd:企業の戦略・SWOT・財務情報
    BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Electro Optic Systems Holdings Ltd (EOS):企業の財務・戦略的SWOT分析
    Electro Optic Systems Holdings Ltd (EOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Oasmia Pharmaceutical AB (OASM):企業の財務・戦略的SWOT分析
    Summary Oasmia Pharmaceutical AB (Oasmia Pharmaceutical) is a pharmaceutical company that develops, manufactures, markets and sells drugs for human and veterinary oncology. The company’s pipeline for human health includes apealea (paclical), currently at registration and approval stage, for treating …
  • SunPower Corp (SPWR):企業の財務・戦略的SWOT分析
    SunPower Corp (SPWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SecureWorks Corp (SCWX):企業の財務・戦略的SWOT分析
    SecureWorks Corp (SCWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Bertelsmann SE & Co. KGaA:企業の戦略・SWOT・財務情報
    Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Mereo Biopharma Group Plc (MPH):企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Harbour Centre Development Ltd:戦略・SWOT・企業財務分析
    Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Harbour Centre Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Repsol SA (REP):電力:M&Aディール及び事業提携情報
    Summary Repsol SA (Repsol) is an integrated oil and gas company. It has presence across the entire value chain: exploration and production, transformation, development and marketing of energy. The company’s upstream business carries out oil and natural gas exploration and production. Its downstream …
  • The Hub Power Co Ltd (HUBC):企業の財務・戦略的SWOT分析
    The Hub Power Co Ltd (HUBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Nakanishi Inc (7716):企業の財務・戦略的SWOT分析
    Nakanishi Inc (7716) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • GMR Infrastructure Ltd (GMRINFRA):電力:M&Aディール及び事業提携情報
    Summary GMR Infrastructure Limited (GMR), a subsidiary of GMR Group, is a construction company. The company executes various projects across airport, energy, transportation and urban infrastructure sectors. The company owns and operates Delhi's Indira Gandhi International Airport, Rajiv Gandhi Inter …
  • Debiopharm International SA:医療機器:M&Aディール及び事業提携情報
    Summary Debiopharm International SA (Debiopharm), a subsidiary of Debiopharm Group is a biopharmaceutical company that develops prescription drugs. The company offers a range of licensing and drug development solutions. It evaluates, searches, and in-licenses promising drug candidates for developmen …
  • Kodiak Sciences Inc (KOD):製薬・医療:M&Aディール及び事業提携情報
    Summary Kodiak Sciences Inc (Kodiak Sciences), formerly Oligasis LLC is a drug development company that discovers new medicines for the healthcare sector. The company provides retinal medicines for treatment of wet and dry forms of age-related macular degeneration. It utilizes proprietary Bioconjuga …
  • Adler Solar Services GmbH:電力:M&Aディール及び事業提携情報
    Summary ADLER Solar Services GmbH (ADLER Solar), formerly ADLER Personal Services GmbH, is a renewable energy company which provides technical solutions and services for solar photovoltaic (PV) industry. The company's service offerings include engineering, procurement and construction management; in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆